Translesion synthesis past platinum DNA adducts by human DNA polymerase μ

被引:36
作者
Havener, JM [1 ]
McElhinny, SAN [1 ]
Bassett, E [1 ]
Gauger, M [1 ]
Ramsden, DA [1 ]
Chaney, SG [1 ]
机构
[1] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA
关键词
D O I
10.1021/bi0270079
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
DNA polymerase mu (pol mu) is a member of the pol X family of DNA polymerases, and it shares a number of characteristics of both DNA polymerase P (pol P) and terminal deoxynucleotidyl transferase (TdT). Because pol P has been shown to perform translesion DNA synthesis past cisplatin (CP)- and oxaliplatin (OX)-GG adducts, we determined the ability of pol mu to bypass these lesions. Pol mu bypassed CP and OX adducts with an efficiency of 14-35% compared to chain elongation on undamaged DNA, which is second only to pol eta in terms of bypass efficiency. The relative ability of pol mu to bypass CP and OX adducts was dependent on both template structure and sequence context. Since pol mu has been shown to be more efficient on gapped DNA templates than on primed single-stranded DNA templates, we determined the ability of pol mu to bypass Pt-DNA adducts on both primed single-stranded and gapped templates. The bypass of Pt-DNA adducts by pol mu was highly error-prone on all templates, resulting in 2, 3, and 4 nt deletions. We postulate that bypass of Pt-DNA adducts by pol mu may involve looping out the Pt-GG adduct to allow chain elongation downstream of the adduct. This reaction appears to be facilitated by the presence of a downstream "acceptor" and a gap large enough to provide undamaged template DNA for elongation past the adduct, although gapped DNA is clearly not required for bypass.
引用
收藏
页码:1777 / 1788
页数:12
相关论文
共 34 条
[21]   EFFECT OF THE DIAMINOCYCLOHEXANE CARRIER LIGAND ON PLATINUM ADDUCT FORMATION, REPAIR, AND LETHALITY [J].
PAGE, JD ;
HUSAIN, I ;
SANCAR, A ;
CHANEY, SG .
BIOCHEMISTRY, 1990, 29 (04) :1016-1024
[22]   Recognition of template-primer and gapped DNA substrates by the human DNA polymerase β [J].
Rajendran, S ;
Jezewska, MJ ;
Bujalowski, W .
JOURNAL OF MOLECULAR BIOLOGY, 2001, 308 (03) :477-500
[23]  
SCHMIDT W, 1993, CANCER RES, V53, P799
[24]   The efficiency and fidelity of translesion synthesis past cisplatin and oxaliplatin GpG adducts by human DNA polymerase β [J].
Vaisman, A ;
Chaney, SG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (17) :13017-13025
[25]   Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts [J].
Vaisman, A ;
Lim, SE ;
Patrick, SM ;
Copeland, WC ;
Hinkle, DC ;
Turchi, JJ ;
Chaney, SG .
BIOCHEMISTRY, 1999, 38 (34) :11026-11039
[26]  
Vaisman A, 1998, CANCER RES, V58, P3579
[27]   Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase η [J].
Vaisman, A ;
Masutani, C ;
Hanaoka, F ;
Chaney, SG .
BIOCHEMISTRY, 2000, 39 (16) :4575-4580
[28]   Structural effect of intra-strand cisplatin-crosslink on palindromic DNA sequences [J].
vanBoom, SSGE ;
Yang, DZ ;
Reedijk, J ;
vanderMarel, GA ;
Wang, AHJ .
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 1996, 13 (06) :989-998
[29]   Sequence- and region-specificity of oxaliplatin adducts in naked and cellular DNA [J].
Woynarowski, JM ;
Chapman, WG ;
Napier, C ;
Herzig, MCS ;
Juniewicz, P .
MOLECULAR PHARMACOLOGY, 1998, 54 (05) :770-777
[30]   DNA HAIRPIN FORMATION IN ADDUCTS WITH PLATINUM ANTICANCER DRUGS - GEL-ELECTROPHORESIS PROVIDES NEW INFORMATION AND A CAVEAT [J].
YOHANNES, PG ;
ZON, G ;
DOETSCH, PW ;
MARZILLI, LG .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1993, 115 (12) :5105-5110